as 12-20-2024 4:00pm EST
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.
Founded: | 2011 | Country: | United States |
Employees: | N/A | City: | LA JOLLA |
Market Cap: | 40.3M | IPO Year: | N/A |
Target Price: | $18.20 | AVG Volume (30 days): | 71.7K |
Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.44 | EPS Growth: | N/A |
52 Week Low/High: | $2.05 - $8.38 | Next Earning Date: | 11-13-2024 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
MIDDLETON FRED A | CALC | Director10% Owner | Dec 6 '24 | Buy | $2.65 | 4,800 | $12,720.00 | 36,514 | |
MIDDLETON FRED A | CALC | Director10% Owner | Nov 1 '24 | Buy | $3.75 | 107,744 | $404,040.00 | 36,514 | |
Roberts Eric W | CALC | CHIEF BUSINESS OFFICER | Nov 1 '24 | Buy | $3.75 | 53,333 | $199,998.75 | 164,706 | |
WILSON ROBERT N | CALC | Director | Nov 1 '24 | Buy | $3.75 | 53,333 | $199,998.75 | 417,529 | |
Leheny A. Rachel | CALC | CHIEF EXECUTIVE OFFICER | Nov 1 '24 | Buy | $3.75 | 20,000 | $75,000.00 | 130,926 | |
Sanderling Venture Partners VI Co Investment Fund LP | CALC | 10% Owner | Nov 1 '24 | Buy | $3.75 | 87,744 | $329,040.00 | 814,300 |
CALC Breaking Stock News: Dive into CALC Ticker-Specific Updates for Smart Investing
PR Newswire
a month ago
PR Newswire
a month ago
PR Newswire
a month ago
PR Newswire
a month ago
Argus Research
2 months ago
PR Newswire
2 months ago
PR Newswire
2 months ago
PR Newswire
2 months ago
The information presented on this page, "CALC CalciMedica Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.